Affimed Plunges After Drug Program Put On Hold Following Patient Death
October 09, 2018 at 14:44 PM EDT
In morning trading, shares of Affimed declined nearly 30% to $3.39.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|